Eyenuk Announces CE Mark and Commercial Launch of Eyeart 2.0, The Second Generation of its Fully Automated Diabetic Retinopathy (DR) Screening Software

CE_logo_nemko_EyeArt_resized

WOODLAND HILLS, Calif. – June 29, 2016 – Eyenuk, Inc., developer of advanced retinal image analysis solutions to identify eye disease, today announced receipt of the CE Mark and the launch of the second generation of its EyeArt fully automated diabetic retinopathy (DR) screening software. The company plans to roll out EyeArt 2.0 to selected, […]

Continue Reading »

Large UK National Health Services (NHS) Study Finds Eyeart Device To Be The Most Sensitive Automated Retinal Image Analysis Technology For Diabetic Retinopathy Screening

WOODLAND HILLS, Calif. – May 2, 2016 – Eyenuk, Inc., developer of advanced retinal image analysis solutions to identify eye disease, today announced results from the first large-scale, independent, comparative study of automated diabetic retinopathy (DR) screening technologies, showing that its EyeArt™ software device rated highest among those tested in sensitivity across all types of […]

Continue Reading »